![Yoon Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 213 313 $ as of 2026-05-30
Yoon Sing Lee worked as VP-Research & Head-Business Development at Aptose Biosciences, Inc. from 2011 to 2012.
Prior to that, he worked as a Research Scientist at GeneSense Technologies, Inc. Dr. Lee holds a doctorate degree from the University of Guelph.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Advance Synergy Bhd.
 Advance Synergy Bhd. Other Consumer ServicesConsumer Services Operates as an investment holding company whose subsidiaries engages in travel and tours, information & communication technology, property development and investment and financial services 0.42% | 2025-03-25 | 10,570,500 ( 0.42% ) | 213 313 $ | 2026-05-30 |
| Companies | Position | End |
|---|---|---|
GeneSense Technologies, Inc.
 GeneSense Technologies, Inc. Part of Aptose Biosciences, Inc., GeneSense Technologies, Inc. is a company based in Toronto, Canada. GeneSense Technologies, Inc. was founded by Aiping H. Young and Jim A. Wright. | Chief Tech/Sci/R&D Officer | 1998-12-31 |
| APTOSE BIOSCIENCES INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Aptose Biosciences, Inc.
 Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
University of Guelph
 University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeneSense Technologies, Inc.
GeneSense Technologies, Inc. Part of Aptose Biosciences, Inc., GeneSense Technologies, Inc. is a company based in Toronto, Canada. GeneSense Technologies, Inc. was founded by Aiping H. Young and Jim A. Wright. |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
